Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus
Yu Tang(Nanjing University of Chinese Medicine), Lingyun Sun(Nanjing University of Chinese Medicine)
Cited by 46
Related Papers
A CD8 T Cell/Indoleamine 2,3‐Dioxygenase Axis Is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus
|Arthritis & Rheumatology|2014|105
Umbilical Cord-Derived Mesenchymal Stem Cells Inhibit Cadherin-11 Expression by Fibroblast-Like Synoviocytes in Rheumatoid Arthritis
|Journal of Immunology Research|2015|51
Tofacitinib Ameliorates Lupus Through Suppression of T Cell Activation Mediated by TGF-Beta Type I Receptor
|Frontiers in Immunology|2021|31
Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials
|Stem Cell Research & Therapy|2025|25
Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1
|Journal of Immunology Research|2023|9